142 related articles for article (PubMed ID: 57022)
21. Identification of nephritic factor as an immunoglobulin.
Williams DG; Bartlett A; Duffus P
Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
Vallota EH; Forristal J; Spitzer RE; Davis NC; West CD
J Exp Med; 1970 Jun; 131(6):1306-24. PubMed ID: 4192571
[TBL] [Abstract][Full Text] [Related]
23. [Progress in the knowledge of complement. II. Nephritic factors].
Leibowitch J; Lesavre P
Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
[No Abstract] [Full Text] [Related]
24. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
[TBL] [Abstract][Full Text] [Related]
25. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
Daha MR; Fearon DT; Austen KF
Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711
[TBL] [Abstract][Full Text] [Related]
26. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
27. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
Whaley K; Ward D; Ruddy S
Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin and complement deposits in lupus glomerulonephritis.
Méry JP; Morel-Maroger L; Boelaert J
Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
[No Abstract] [Full Text] [Related]
30. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
Ruley EJ; Forristal J; Davis NC; Andres C; West CD
J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
[TBL] [Abstract][Full Text] [Related]
31. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
Arroyave CM; Vallota EH; Müller-Eberhard HJ
J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
[No Abstract] [Full Text] [Related]
32. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
Kim Y; Vernier RL; Fish AJ; Michael AF
Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
[TBL] [Abstract][Full Text] [Related]
33. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
34. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
[TBL] [Abstract][Full Text] [Related]
35. Editorial: Glomerulonephritis, complement and C3NeF.
Fearon DT
N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
[No Abstract] [Full Text] [Related]
36. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
Craddock CF; Richards NP; Powell RJ; Morgan AG
Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
[TBL] [Abstract][Full Text] [Related]
37. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
38. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
West CD; Ruley EJ; Spitzer RE; Davis NC
Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
[No Abstract] [Full Text] [Related]
39. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
[TBL] [Abstract][Full Text] [Related]
40. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]